Citation: Dw. Abbott et al., DOUBLE-STRAND BREAK REPAIR DEFICIENCY AND RADIATION SENSITIVITY IN BRCA2 MUTANT CANCER-CELLS, Journal of the National Cancer Institute, 90(13), 1998, pp. 978-985
Citation: Ms. Steiner et al., ANTISENSE C-MYC RETROVIRAL VECTOR SUPPRESSES ESTABLISHED HUMAN PROSTATE-CANCER, Human gene therapy, 9(5), 1998, pp. 747-755
Citation: Dl. Page et al., DIRECTIONS AND ASSOCIATIONS IN PREMALIGNANT BREAST DISEASE - THE IMPORTANT ROLE OF NON-COMEDO DUCTAL CARCINOMA IN-SITU, Endocrine-related cancer, 4(1), 1997, pp. 105-112
Citation: Jt. Holt et Sa. Thorpe, THE PROPAGATION OF HIGH-FREQUENCY INTERNAL WAVES IN THE CELTIC-SEA, Deep-sea research. Part 1. Oceanographic research papers, 44(12), 1997, pp. 2087-2116
Citation: Dw. Abbott et Jt. Holt, FINKEL-BISKIS-REILLY OSTEOSARCOMA VIRUS V-FOS INHIBITS ADIPOGENESIS AND BOTH THE ACTIVITY AND EXPRESSION OF CCAAT ENHANCER BINDING-PROTEIN-ALPHA, A KEY REGULATOR OF ADIPOCYTE DIFFERENTIATION/, The Journal of biological chemistry, 272(51), 1997, pp. 32454-32462
Citation: Dw. Abbott et Jt. Holt, FINKEL-BISKIS-REILLY MOUSE OSTEOSARCOMA VIRUS V-FOS INHIBITS THE CELLULAR-RESPONSE TO IONIZING-RADIATION IN A MYRISTOYLATION-DEPENDENT MANNER, The Journal of biological chemistry, 272(22), 1997, pp. 14005-14008
Authors:
KING MC
GOWN AM
HERNANDEZ RG
WELCSH PL
OBERMILLER PS
REDLINFRAZIER S
JENSEN RA
HOLT JT
TAIT DL
Citation: Mc. King et al., PHASE-I HUMAN GENE-THERAPY TRIAL OF RETROVIRAL LXSN-BRCA1 FOR SPORADIC AND INHERITED OVARIAN-CANCER, American journal of human genetics, 61(4), 1997, pp. 183-183
Authors:
JENSEN RA
THOMPSON ME
JETTON TL
VANDERMEER R
HELOU B
ARTEAGA CL
PAGE DL
HOLT JT
TRONICK SR
GOWN AM
SKELLY M
OSTERMEYER B
SCHIELTZ D
SZABO CI
KING MC
Citation: Ra. Jensen et al., BRCA1 PROTEIN PRODUCTS - ANTIBODY SPECIFICITY ... FUNCTIONAL MOTIFS ... AND SECRETED TUMOR SUPPRESSORS - REPLY, Nature genetics, 13(3), 1996, pp. 269-272
Citation: Jt. Holt et al., GENE-THERAPY FOR THE TREATMENT OF METASTATIC BREAST-CANCER BY IN-VIVOTRANSDUCTION WITH BREAST-TARGETED RETROVIRAL VECTOR EXPRESSING ANTISENSE C-FOS RNA, Human gene therapy, 7(11), 1996, pp. 1367-1380
Citation: Rm. Jotte et Jt. Holt, MYRISTYLATION OF FBR V-FOS DICTATES THE DIFFERENTIATION PATHWAYS IN MALIGNANT OSTEOSARCOMA, The Journal of cell biology, 135(2), 1996, pp. 457-467
Citation: Cl. Arteaga et Jt. Holt, TISSUE-TARGETED ANTISENSE C-FOS RETROVIRAL VECTOR INHIBITS ESTABLISHED BREAST-CANCER XENOGRAFTS IN NUDE-MICE, Cancer research, 56(5), 1996, pp. 1098-1103
Authors:
THOMPSON ME
JENSEN RA
OBERMILLER PS
PAGE DL
HOLT JT
Citation: Me. Thompson et al., DECREASED EXPRESSION OF BRCA1 ACCELERATES GROWTH AND IS OFTEN PRESENTDURING SPORADIC BREAST-CANCER PROGRESSION, Nature genetics, 9(4), 1995, pp. 444-450
Citation: Sa. Thorpe et Jt. Holt, THE EFFECTS OF LATERALLY SLOPING UPPER AND LOWER BOUNDARIES ON WAVES AND INSTABILITY IN STRATIFIED SHEAR FLOWS, Journal of Fluid Mechanics, 286, 1995, pp. 49-65
Citation: C. Robinsonbenion et al., GENE TRANSPLANTATION - COMBINED ANTISENSE INHIBITION AND GENE REPLACEMENT STRATEGIES, Leukemia, 8, 1994, pp. 190000152-190000155
Citation: Ra. Jensen et al., IDENTIFICATION OF GENES EXPRESSED IN PREMALIGNANT BREAST DISEASE BY MICROSCOPY-DIRECTED CLONING, Proceedings of the National Academy of Sciences of the United Statesof America, 91(20), 1994, pp. 9257-9261
Citation: Ra. Jensen et al., IDENTIFICATION OF GENES OVEREXPRESSED IN NON-COMEDO DUCTAL CARCINOMA IN-SITU OF THE BREAST (DCIS) BY USE OF DIFFERENTIAL CDNA LIBRARY SCREENING, Laboratory investigation, 70(1), 1994, pp. 10000016-10000016
Citation: Rm. Jotte et al., MYRISTYLATION-DEPENDENT TRANSACTIVATION BY FBR V-FOS IS REGULATED BY C EBP/, The Journal of biological chemistry, 269(23), 1994, pp. 16383-16396